ARDS Clinical Trial
— PEEP-RéaOfficial title:
Pulmonary and Ventilatory Effects of End-expiratory Positive Pressure Optimization in Intubated ICU Patients With Healthy Lungs or Acute Respiratory Distress Syndrome. A Randomized Controlled Trial
PEEP titration is a recommended during invasive mechanical ventilation of ICU patients. However, little is known about the right way to conduct this titration. PEEP titration can be conducted by a stepwise increase in PEEP level, or following an ARM and a consecutive stepwise decrease in PEEP level. Those 2 methods will be explored in intubated ICU patients either with healthy lung or ARDS lungs. Physiological exploration will include end-expiratory lung volume measurements, driving pressure, compliance and electro-impedance tomography at each PEEP level.
Status | Recruiting |
Enrollment | 45 |
Est. completion date | October 31, 2021 |
Est. primary completion date | September 12, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient over 18 years of age - ICU patients with healthy lungs or lungs with Acute Respiratory Distress Syndrome (according to Berlin criteria) under mechanically invasive controlled ventilation (intubation or tracheotomy) in the early phase of admission (< 12h) - Patient deeply sedated (BIS between 30 and 50) and possibly under neuromuscular blocking agents (TOF < 2/4 at the orbicular) in case of inspiratory efforts - Patient hemodynamically stable with an optimized volemia using a monitoring system (see protocol). - Consent to participate - Patient benefiting from a Social Security Insurance Exclusion Criteria: - Refusal to participate to the proposed study - Obese patient with BMI = 35 kg.cm-2 - Significant hemodynamic instability defined as > 20% increase in catecholamine doses during the last hour, despite optimization of blood volume according to a pre-established protocol - Contraindication to the use of the electro-impedance tomography technique - Thoracic lesions - Chest bandages - Pace-maker/Implantable defibrillator - Contraindication to the performance of an alveolar recruitment maneuver - Major Emphysema |
Country | Name | City | State |
---|---|---|---|
France | CHU | Clermont-Ferrand |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruited lung volume at each PEEP level between the 2 strategies (incremental or decremental). | : The main endpoint is the difference between the recruited lung volume measured by nitrogen washin-washout method at the end of each PEEP level (5th minute) with the basal value measured at the beginning of the protocol, between decremental and incremental stepwise PEEP titration | The last minute of each Peep Step | |
Secondary | Homogeneity of pulmonary aeration | Evaluation by using the Electrical Impedance Tomography (EIT) - derived index Center of ventilation (CoV) | The last minute of each Peep Step | |
Secondary | Homogeneity of pulmonary aeration | Evaluation by using the Global Inhomogeneity index (GI) by electro-impedance tomography (EIT) | The last minute of each Peep Step | |
Secondary | Regional impedance variation | Evaluation of regional impedance variation (TIV: Tidal Impedance Variation) by EIT | Measurement during the last minute of each PEEP step | |
Secondary | Atelectrauma | Assessement of atelectrauma (RVD: Regional Ventilation Delay) by EIT | Measurement during the last minute of each PEEP step | |
Secondary | Lung volume variations | Evaluation of lung volume variations by EIT (EELI : End Expiratory Lung Impedance) | Measurement during the last minute of each PEEP step | |
Secondary | Mechanical power delivered Mechanical power delivered | By using the formula : Power rs =RR·{?V² ·[1/2 ·ELrs +RR·((1+I:E) / (60·I:E) x Raw ]+?V·PEEP}. (Gattinoni, Intensive Care Medicine 2016) | Measurement during the last minute of each PEEP step | |
Secondary | Alveolar strain | Alveolar strain as assessed by TV/FRC where TV stands for tidal volume and FRC functional residual capacity. | Measurement during the last minute of each PEEP step | |
Secondary | Recruited lung volume | Evaluation of recruited lung volumes (Dellamonica, Intensive Care Medicine 2011) | Measurement during the last minute of each PEEP step | |
Secondary | Ventilatory dead space | Ventilatory dead space = Vd/Vt. Where Vd is the dead space volume and Vt is the tidal volume | Measurement during the last minute of each PEEP step | |
Secondary | Ventilatory parameters | Evaluation of the compliance = TV / (Pplat - PEEP) where TV stands for tidal volume, Pplat stands for Plateau Pressure and PEEP stands for Positive End-Expiratory Pressure | Measurement during the last minute of each PEEP step | |
Secondary | Ventilatory parameters | Evaluation of the driving pressure | Measurement during the last minute of each PEEP step | |
Secondary | Ventilatory parameters | Evaluation of the plateau pressure | Measurement during the last minute of each PEEP step |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04435613 -
Clinical and Physiological Assessment of a Nearly Ultra-protective Lung Ventilation Strategy: A Quasi-experimental Preliminary Study in ARDS Patients
|
N/A | |
Enrolling by invitation |
NCT05020210 -
Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
|
||
Completed |
NCT04468971 -
REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia
|
Phase 1 | |
Completed |
NCT04505592 -
Tenecteplase in Patients With COVID-19
|
Phase 2 | |
Completed |
NCT04493242 -
Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
|
Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Completed |
NCT02265198 -
Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT01949272 -
Optimization of PEEP for Alveolar Recruitment in ARDS
|
N/A | |
Not yet recruiting |
NCT01668368 -
Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance
|
N/A | |
Completed |
NCT01881061 -
Lung Sonography in Patients With Acute Respiratory Distress Syndrome in Intensive Care Unit
|
N/A | |
Completed |
NCT00808691 -
Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
|
N/A | |
Completed |
NCT05035589 -
The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
|
||
Recruiting |
NCT04764032 -
Right Ventricular Dysfunction in Ventilated Patients With COVID-19
|
||
Completed |
NCT04556513 -
Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
|
||
Recruiting |
NCT06036056 -
NMR Based Metabolomics Kinetics in ARDS Patients
|
||
Recruiting |
NCT04643691 -
Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS
|
Phase 2 | |
Completed |
NCT04395911 -
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
|
N/A | |
Not yet recruiting |
NCT05341687 -
Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
|
||
Recruiting |
NCT05056090 -
Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome.
|
N/A | |
Recruiting |
NCT04694742 -
Ventilatory Efficiency in Critically Ill COVID-19 Patients
|